Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

125 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Donor-Derived Malignancy and Transplantation Morbidity: Risks of Patient and Donor Genetics in Allogeneic Hematopoietic Stem Cell Transplantation.
Williams LS, Williams KM, Gillis N, Bolton K, Damm F, Deuitch NT, Farhadfar N, Gergis U, Keel SB, Michelis FV, Panch SR, Porter CC, Sucheston-Campbell L, Tamari R, Stefanski HE, Godley LA, Lai C. Williams LS, et al. Among authors: michelis fv. Transplant Cell Ther. 2024 Mar;30(3):255-267. doi: 10.1016/j.jtct.2023.10.018. Epub 2023 Oct 31. Transplant Cell Ther. 2024. PMID: 37913908 Review.
Predictors of Outcomes of Therapy-Related Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation.
Nampoothiri RV, Law AD, Lam W, Chen C, Al-Shaibani Z, Loach D, Michelis FV, Kim DDH, Mattsson J, Kumar R, Lipton JH, Viswabandya A. Nampoothiri RV, et al. Among authors: michelis fv. Hematol Oncol Stem Cell Ther. 2022 Mar 1;15(1):27-35. doi: 10.1016/j.hemonc.2021.03.003. Hematol Oncol Stem Cell Ther. 2022. PMID: 33775624 Free article.
Association of Factors Influencing Selection of Upfront Hematopoietic Cell Transplantation versus Nontransplantation Therapies in Myelofibrosis.
Smith E, Huang J, Viswabandya A, Maze D, Malik S, Cheung V, Siddiq N, Claudio J, Arruda A, Kennedy J, Bankar A, Law AD, Lam W, Michelis FV, Kim D, Lipton J, Kumar R, Mattsson J, McNamara C, Sibai H, Xu W, Gupta V. Smith E, et al. Among authors: michelis fv. Transplant Cell Ther. 2021 Jul;27(7):600.e1-600.e8. doi: 10.1016/j.jtct.2021.03.027. Epub 2021 Mar 30. Transplant Cell Ther. 2021. PMID: 33798769 Free article.
Experience Using Anti-Thymocyte Globulin With Post-Transplantation Cyclophosphamide for Graft-Versus-Host Disease Prophylaxis in Peripheral Blood Haploidentical Stem Cell Transplantation.
Salas MQ, Atenafu EG, Law AD, Lam W, Pasic I, Chen C, Dong Hwan Kim D, Michelis FV, Gerbitz A, Lipton JH, Mattsson J, Kumar R, Viswabandya A. Salas MQ, et al. Among authors: michelis fv. Transplant Cell Ther. 2021 May;27(5):428.e1-428.e9. doi: 10.1016/j.jtct.2021.02.007. Epub 2021 Feb 13. Transplant Cell Ther. 2021. PMID: 33965185 Free article.
Haploidentical vs sibling, unrelated, or cord blood hematopoietic cell transplantation for acute lymphoblastic leukemia.
Wieduwilt MJ, Metheny L, Zhang MJ, Wang HL, Estrada-Merly N, Marks DI, Al-Homsi AS, Muffly L, Chao N, Rizzieri D, Gale RP, Gadalla SM, Cairo M, Mussetti A, Gore S, Bhatt VR, Patel SS, Michelis FV, Inamoto Y, Badawy SM, Copelan E, Palmisiano N, Kharfan-Dabaja MA, Lazarus HM, Ganguly S, Bredeson C, Diaz Perez MA, Cassaday R, Savani BN, Ballen K, Martino R, Wirk B, Bacher U, Aljurf M, Bashey A, Murthy HS, Yared JA, Aldoss I, Farhadfar N, Liu H, Abdel-Azim H, Waller EK, Solh M, Seftel MD, van der Poel M, Grunwald MR, Liesveld JL, Kamble RT, McGuirk J, Munker R, Cahn JY, Lee JW, Freytes CO, Krem MM, Winestone LE, Gergis U, Nathan S, Olsson RF, Verdonck LF, Sharma A, Ringdén O, Friend BD, Cerny J, Choe H, Chhabra S, Nishihori T, Seo S, George B, Baxter-Lowe LA, Hildebrandt GC, de Lima M, Litzow M, Kebriaei P, Hourigan CS, Abid MB, Weisdorf DJ, Saber W. Wieduwilt MJ, et al. Among authors: michelis fv. Blood Adv. 2022 Jan 11;6(1):339-357. doi: 10.1182/bloodadvances.2021004916. Blood Adv. 2022. PMID: 34547770 Free PMC article.
Risk classification at diagnosis predicts post-HCT outcomes in intermediate-, adverse-risk, and KMT2A-rearranged AML.
Menghrajani K, Gomez-Arteaga A, Madero-Marroquin R, Zhang MJ, Bo-Subait K, Sanchez J, Wang HL, Aljurf M, Assal A, Bacher VU, Badawy SM, Bejanyan N, Bhatt VR, Bredeson C, Byrne M, Castillo P, Cerny J, Chhabra S, Ciurea SO, DeFilipp Z, Farhadfar N, Gadalla S, Gale RP, Ganguly S, Gowda L, Grunwald MR, Hashmi S, Hildebrandt G, Kanakry CG, Kansagra A, Khimani F, Krem M, Lazarus H, Liu H, Martino R, Michelis FV, Nathan S, Nishihori T, Olsson R, Reshef R, Rizzieri D, Rowe JM, Savani BN, Seo S, Sharma A, Solh M, Ustun C, Verdonck LF, Hourigan C, Sandmaier B, Litzow M, Kebriaei P, Weisdorf D, Zhang Y, Tallman MS, Saber W. Menghrajani K, et al. Among authors: michelis fv. Blood Adv. 2022 Jan 8;6(3):828-847. doi: 10.1182/bloodadvances.2021004881. Blood Adv. 2022. PMID: 34551064 Free PMC article.
Bloodstream Infections and Outcomes Following Allogeneic Hematopoietic Cell Transplantation: A Single-Center Study.
Carreira AS, Salas MQ, Remberger M, Basso IN, Law AD, Lam W, Pasic I, Kim D, Michelis FV, Viswabandya A, Gerbitz A, Lipton JH, Husain S, Kumar R, Mattsson J. Carreira AS, et al. Among authors: michelis fv. Transplant Cell Ther. 2022 Jan;28(1):50.e1-50.e8. doi: 10.1016/j.jtct.2021.10.008. Epub 2021 Oct 14. Transplant Cell Ther. 2022. PMID: 34656808 Free article.
Improving Safety and Outcomes After Allogeneic Hematopoietic Cell Transplantation: A Single-Center Experience.
Salas MQ, Pasic I, Remberger M, Novitzky-Basso I, Law AD, Lam W, Chen C, Kim DDH, Michelis FV, Gerbitz A, Viswabandya A, Lipton JH, Kumar R, Mattsson J. Salas MQ, et al. Among authors: michelis fv. Transplant Cell Ther. 2022 May;28(5):265.e1-265.e9. doi: 10.1016/j.jtct.2022.02.001. Epub 2022 Feb 6. Transplant Cell Ther. 2022. PMID: 35139398 Free article.
Interaction Between High-Dose Intravenous Busulfan and Post-Transplantation Cyclophosphamide on Hemorrhagic Cystitis After Allogeneic Hematopoietic Cell Transplantation.
Santos Carreira A, Salas MQ, Remberger M, Novitzky-Basso I, Law AD, Lam W, Pasic I, Mazzulli T, Cserti-Gazdewich C, Kim DDH, Michelis FV, Viswabandya A, Gerbitz A, Lipton JH, Kumar R, Hassan M, Mattsson J. Santos Carreira A, et al. Among authors: michelis fv. Transplant Cell Ther. 2023 Sep;29(9):581.e1-581.e8. doi: 10.1016/j.jtct.2023.07.007. Epub 2023 Jul 10. Transplant Cell Ther. 2023. PMID: 37437765 Free article.
125 results